Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Asian Pac J Cancer Prev ; 21(4): 1005-1009, 2020 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-32334462

RESUMEN

BACKGROUND: Betel quid chewing is more common among the older generation in rural areas of Malaysia. Oral cancer in Asia has been associated with the habit of chewing betel quid and areca nut. OBJECTIVE:   This study aims to investigate the cytotoxic effects of betel quid and areca nut extracts on the fibroblast (L929), mouth-ordinary-epithelium 1 (MOE1) and oral squamous cell carcinoma (HSC-2) cell lines. METHODS: L929, MOE1 and HSC-2 cells were treated with 0.1, 0.2 and 0.4 g/ml of betel quid and areca nut extracts for 24, 48 and 72 h. MTT assay was performed to assess the cell viability. RESULTS: Both extracts, regardless of concentration, significantly reduced the cell viability of L929 compared with the control (P<0.05). Cell viability of MOE1 was significantly enhanced by all betel quid concentrations compared with the control (P<0.05). By contrast, 0.4 g/ml of areca nut extract significantly reduced the cell viability of MOE1 at 48 and 72 h of incubation. Cell viability of HSC-2 was significantly lowered by all areca nut extracts, but 0.4 g/ml of betel quid significantly increased the cell viability of HSC-2 (P<0.05). CONCLUSION: Areca nut extract is cytotoxic to L929 and HSC-2, whereas the lower concentrations of areca nut extract significantly increased the cell viability of MOE1 compared to the higher concentration and control group. Although betel quid extract is cytotoxic to L929, the same effect is not observed in MOE1 and HSC-2 cell lines. Further investigations are needed to clarify the mechanism of action.
.


Asunto(s)
Apoptosis/efectos de los fármacos , Areca/química , Carcinoma de Células Escamosas/patología , Fibroblastos/efectos de los fármacos , Neoplasias de la Boca/patología , Neoplasias Glandulares y Epiteliales/patología , Extractos Vegetales/farmacología , Animales , Areca/clasificación , Carcinoma de Células Escamosas/tratamiento farmacológico , Supervivencia Celular , Células Cultivadas , Fibroblastos/patología , Humanos , Ratones , Neoplasias de la Boca/tratamiento farmacológico , Neoplasias Glandulares y Epiteliales/tratamiento farmacológico , Nueces/química
2.
Asian Pac J Cancer Prev ; 16(18): 8365-70, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26745086

RESUMEN

BACKGROUND: Shammah is a traditional form of snuff dipping tobacco (a smokeless tobacco form) that is commonly used in Yemen. Oral mucosal changes due to the use of shammah can usually be observed in the mucosal surfaces that the product touches. The aim of this study was to determine the association between shammah use and oral leukoplakia-like lesions. Other associated factors were also determined. MATERIALS AND METHODS: A cross sectional study was conducted on 346 randomly selected adult males. Multi-stage random sampling was used to select the study location. After completing the structured questionnaire interviews, all the participants underwent clinical exanimation for screening of oral leukoplakia-like lesions Clinical features of oral leukoplakia-like lesion were characterized based on the grades of Axell et al (1976). Univariable logistic regression and multivariable logistic regression were used to assess the potential associated factors. RESULTS: Out of 346 male participants aged 18 years and older, 68 (19.7%) reported being current shammah users. The multivariable analysis revealed that age, non-formal or primary level of education, former shammah user, current shammah user, and frequency of shammah use per day were statistically associated with the presence of oral leukoplakia-like lesions [Adjusted odds ratio (AOR) = 1.03; 95% confidence interval (CI) : 1.01, 1.06; P= 0.006], (AOR= 8.65; 95% CI: 2.81, 26.57; P= 0.001), (AOR= 3.65; 95% CI: 1.40, 9.50; P= 0.008), (AOR= 12.99; 95% CI: 6.34, 26.59; P= 0.001), and (AOR= 1.17; 95% CI: 1.02, 1.36; P= 0.026), respectively. CONCLUSIONS: The results revealed oral leukoplakia-like lesions to be significantly associated with shammah use. Therefore, it is important to develop comprehensive shammah prevention programs in Yemen.


Asunto(s)
Leucoplasia Bucal/etiología , Neoplasias de la Boca/etiología , Tabaquismo/etiología , Tabaco sin Humo/efectos adversos , Adolescente , Adulto , Anciano , Estudios Transversales , Estudios de Seguimiento , Humanos , Leucoplasia Bucal/epidemiología , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/epidemiología , Pronóstico , Encuestas y Cuestionarios , Tabaquismo/epidemiología , Yemen/epidemiología , Adulto Joven
3.
J Endod ; 37(5): 667-72, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21496668

RESUMEN

INTRODUCTION: This study evaluated the formation of reparative hard tissues in baboon pulps after Emdogain (EMD) application in conjunction with 3 pulp-capping materials. METHODS: Thirty-two premolars in four 3-year-old baboons were randomly assigned to 1 of 3 pulp-capping materials. A split-mouth design and intra-animal side randomization were applied to 3 experimental groups (calcium hydroxide, ProRoot White mineral trioxide aggregate, white Portland cement) and the control group (no pulp-capping material). In the hybrid EMD approach, a small drop of EMD was placed over the exposure site after arrest of hemorrhage. The designated pulp-capping material was placed over the EMD, followed by placement of resin-modified glass ionomer cement over the set/unset pulp-capping material. The animals were killed after 4 months. Histomorphometric analysis and micro-computed tomography were performed on the retrieved specimens. RESULTS: All groups capped with EMD and 1 of the 3 capping materials exhibited similar reparative tissue thickness (P > .05). Dentin tunnel defects were absent in the mineral trioxide aggregate and Portland cement groups after the use of EMD. However, only a tubular was identified from all specimens. CONCLUSIONS: Mineral trioxide aggregate produces a better quality reparative hard tissue response with the adjunctive use of Emdogain, when compared with the use of calcium hydroxide.


Asunto(s)
Proteínas del Esmalte Dental/uso terapéutico , Recubrimiento de la Pulpa Dental/métodos , Materiales de Recubrimiento Pulpar y Pulpectomía/uso terapéutico , Compuestos de Aluminio/uso terapéutico , Animales , Compuestos de Calcio/uso terapéutico , Hidróxido de Calcio/uso terapéutico , Amalgama Dental/química , Cementos Dentales/uso terapéutico , Pulpa Dental/efectos de los fármacos , Exposición de la Pulpa Dental/terapia , Restauración Dental Permanente , Dentina/efectos de los fármacos , Dentina Secundaria/efectos de los fármacos , Combinación de Medicamentos , Cementos de Ionómero Vítreo/química , Procesamiento de Imagen Asistido por Computador , Óxidos/uso terapéutico , Papio , Distribución Aleatoria , Cementos de Resina/química , Silicatos/uso terapéutico , Microtomografía por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA